Trademark: 97049618
Status Date
Thursday, December 14, 2023
Filing Date
Tuesday, September 28, 2021
Published for Opposition
Tuesday, May 3, 2022
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis
Dec 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 14, 2023
Sou Extension 3 Granted
Dec 14, 2023
Sou Extension 3 Filed
Dec 14, 2023
Sou Teas Extension Received
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Extension 2 Granted
Jun 27, 2023
Sou Extension 2 Filed
Jun 27, 2023
Sou Teas Extension Received
Dec 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 23, 2022
Sou Extension 1 Granted
Dec 23, 2022
Sou Extension 1 Filed
Dec 23, 2022
Sou Teas Extension Received
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
May 3, 2022
Published For Opposition
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
Mar 29, 2022
Approved For Pub - Principal Register
Mar 28, 2022
Assigned To Examiner
Oct 27, 2021
New Application Office Supplied Data Entered
Oct 1, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
